Pediatric Microbiota SCTBo

Research team on microbiome in pediatric patients affected by oncological and hematological diseases @UniversityofBologna. Share ideas, welcome collaborations.

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Proud of these results!! https://t.co/SzZwrVcRs2

[ASH @ASH_hematology]

🆕 in @BloodJournal: Increased gut microbiome diversity may lead to better outcomes among children receiving stem cell transplants. Read more: https://t.co/ghzPKvImYK

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Very proud to share our new paper in Blood Journal! First time in children Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as predictor of mortality in children https://t.co/sl8k8C7gyH

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Very proud to share our new paper! Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis https://t.co/HHATw0wkw1

[Prof. Feynman @ProfFeynman]

The difference between Knowledge and Experience.

[Francesco Baccelli @FrancescoBacce3]

First time at EHA congress
Amazing microbiome session at #EHA2023 in Frankfurt
Thanks to @young_eha

@EHA_Hematology @PedMicroSCTBo @ZaninettiCarlo @TerezaFaitova @MelodySmithMD

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

We are very happy to share our new paper on Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML! https://t.co/HHATw0wkw1

[Blood Journals Portfolio @BloodPortfolio]

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche https://t.co/LKQRqxXyRb

[Fondazione Veronesi @Fondaz_Veronesi]

La leucemia mieloide acuta è un tumore raro del sangue ancora da studiare. Nasce la Rete italiana “PALM” di istituti specializzati in campo oncoematologico coordinata dall’ @bambinogesu , finanziata da Fondazione Umberto Veronesi➡https://t.co/I3UZN9w9dv

[Segata Lab @cibiocm]

"The person-to-person transmission landscape of the gut and oral microbiomes". Our work on microbiome stransmission published today open-access in @Nature! Fantastic work @MireiaVallesc, the whole @cibiocm group @CIBIO_UniTrento and all the collaborators! https://t.co/EB4TFlIDIh

[ASTCT @ASTCT]

There is an unmet need for better methods of diagnosing GvHD, identifying at-risk patients & determining which patients are at highest risk of severity & poor outcomes. Read about updated GVHD biomarkers on Nucleus: https://t.co/yPEhUwcSV9

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Good mourning researchers 🤣🤣

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Very happy to share our paper on effect of levofloxacin prophylaxis and parenteral nutrition on intestinal microbial in pediatric patients undergoing HSCT… we test a new network approach! #microbiota https://t.co/dYkPTe5VU1

[Blood Journals Portfolio @BloodPortfolio]

Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease https://t.co/mhmM05xaCz #SCD

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Very interesting pov ‘Disruptive’ science has declined — and no one knows why https://t.co/dCrHW76voV

[Fondazione Veronesi @Fondaz_Veronesi]

Salutiamo Gianluca Vialli con le parole che lui ha dedicato ai nostri ricercatori e alle nostre ricercatrici solo pochi mesi fa. Ci stringiamo alla sua famiglia in questo momento.

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Pharmacomicrobiomics in Pediatric Oncology: The Complex Interplay between Commonly Used Drugs and Gut Microbiome https://t.co/Xw3d8EfuTC #mdpiijms via @IJMS_MDPI

[Pediatric Microbiota SCTBo @PedMicroSCTBo]

Interesting paper on mycobiome in #fmt Profiling the fungal microbiome after FMT for graft-versus-host disease: insights from a phase 1 interventional study - ScienceDirect https://t.co/a6ZyfLtogk

[Robert Brodsky @DocsDock200]

High dose cyclophosphamide (HiCY) has changed landscape of alloBMT by expanding donor pool and allowing for relative safe and effective use of haplo donors. Esp useful in non-malig dz such as SAA and SCD where cure rates now approach 90%. Why does HiCY work?

[Prof. Feynman @ProfFeynman]

Knowledge isn't free. You have to pay attention.